PCSK9 inhibition across a wide spectrum of patients: One size fits all?
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- PCSK9 Inhibition & CV Outcomes: Review of Lipid Targets and Treatment StrategiesUnderstanding new PCSK9 outcome data: From the LDL-C hypothesis to LDL-c causality
John Chapman
- PCSK9 Inhibition & CV Outcomes: Review of Lipid Targets and Treatment StrategiesPCSK9 inhibition & CV events: Review of recent and upcoming hard endpoint outcome trials
Peter Sever, MD
